Days after giving our favorite Carlsbad-based life sciences company a completely uninformed “buy” rating, Invitrogen’s board of directors announces that the stock is going to split.
The stock split will be distributed May 27 to shareholders of record as of May 16. . . .Shares of Invitrogen (nasdaq: IVGN – news – people ) rose 51 cents to $94.08 in after-hours electronic trading, after falling 35 cents to close at $93.57 in the regular trading session.
We may wait until after the split to see where the stock settles out.
[Link: Forbes.com]
RSS Feed-Posts